APOA1 and atherosclerosis: Several studies have demonstrated that ApoA1 exerts regulatory effects on cholesterol levels, IL-2 receptor expression, and IL-6 expression in Treg cells during the progression of atherosclerosis, thereby impeding the transition from exTregs to Tfh cells and ultimately reducing atherosclerosis (73, 74).